Form D · Biotechnology
PROSETTA BIOCONFORMATICS INC
San Francisco, CA · CIK 0001445257
Offering snapshot reported Jul 24, 2012 · SEC filing
- Reported sold
- $2.04M Offering amount: $15.8M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $315 Reported outside-investor minimum
- First sale
- Jul 5, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 24, 2012 | Initial | $2,039,850 | No comparison | 18 | SEC filing |
| Jun 15, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Sep 11, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-181684
Source: Form D, filed Jul 24, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Thomas Coulson | Director |
| Michael D. Farmer | Director, Executive |
| Thomas Higgins | Director |
| David Keyes | Director |
| Vishwanath Lingappa | Director, Executive |
| Larry Litvak | Director |
| Karl Manheim | Director |
| Mike Mc Cune | Director |
| Abel Weinrib | Director |
| Abel Weinrin | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
670 5 Th Street
San Francisco, CA, 94107
San Francisco, CA, 94107